Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-κB are required for C2C12-RasV12C40 myoblast differentiation

Endocrinology

Volumn 149, Issue 2, 2008, Pages 793-801

  De Alvaro, Cristina ^a   Nieto Vazquez, Iria ^a   Rojas, Jose Maria ^b   Lorenzo, Margarita ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; FORKHEAD BOX O PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; S6 KINASE; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; GENETIC TRANSFECTION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; ONCOGENE H RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RETINOBLASTOMA; SKELETAL MUSCLE;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL NUCLEUS; ETS-DOMAIN PROTEIN ELK-1; FORKHEAD TRANSCRIPTION FACTORS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE FIBERS; MUSCLE, SKELETAL; MUTAGENESIS; MYOBLASTS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 38549171104     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0657     Document Type: Article

References (45)

1. Weintraub H 1993 The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75:1241-1244
2. Ewton DZ, Roof SL, Magri KA, McWade FJ, Florini JR 1994 IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. J Cell Physiol 161:277-284
3. Bach LA, Salemi R, Leeding KS 1995 Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II-induced proliferation and differentiation of L6A1 rat myoblasts. Endocrinology 136:5061-5069
4. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR 1997 The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272:6653-6662
5. White MF 2003 Insulin signaling in health and disease. Science 302:1710-1711
6. Kaliman P, Canicio J, Shepherd PR, Beeton CA, Testar X, Palacin M, Zorzano A 1998 Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol Endocrinol 12:66-77
7. Calera MR, Pilch PF 1998 Induction of Akt-2 correlates with differentiation in Sol8 muscle cells. Biochem Biophys Res Commun 251:835-841
8. Cuenda A, Cohen P 1999 Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J Biol Chem 274:4341-4346
9. Baeza-Raja B, Munoz-Canoves P 2004 p38 MAPK-induced nuclear factor-κB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol Biol Cell 15:2013-2026
10. Conejo R, Lorenzo M 2001 Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts. J Cell Physiol 187:96-108
11. Conejo R, Valverde AM, Benito M, Lorenzo M 2001 Insulin produces myogenesis in C2C12 myoblasts by induction of NF-κB and downregulation of AP-1 activities. J Cell Physiol 186:82-94
12. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD, Glass DJ 1999 Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286:1738-1741
13. Canicio J, Ruiz-Lozano P, Carrasco M, Palacin M, Chien K, Zorzano A, Kaliman P 2001 Nuclear factor κB-inducing kinase and IκB kinase-α signal skeletal muscle cell differentiation. J Biol Chem 276:20228-20233
14. Kumar A, Murphy R, Robinson P, Wei L, Boriek AM 2004 Cyclic mechanical strain inhibits skeletal myogenesis through activation of focal adhesion kinase, Rac-1 GTPase, and NF-κB transcription factor. FASEB J 18:1524-1535
15. Khurana A, Dey CS 2002 Involvement of Elk-1 in L6E9 skeletal muscle differentiation. FEBS Lett 527:119-124
16. Iyer D, Chang D, Marx J, Wei L, Olson EN, Parmacek MS, Balasubramanyam A, Schwartz RJ 2006 Serum response factor MADS box serine-162 phosphorylation switches proliferation and myogenic gene programs. Proc Natl Acad Sci USA 103:4516-4521
17. Hribal ML, Nakae J, Kitamura T, Shutter JR, Accili D 2003 Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J Cell Biol 162:535-541
18. Bois PR, Grosveld GC 2003 FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts. EMBO J 22:1147-1157
19. de Alvaro C, Martinez N, Rojas JM, Lorenzo M 2005 Sprouty-2 overexpression in C2C12 cells confers myogenic differentiation properties in the presence of FGF2. Mol Biol Cell 16:4454-4461
20. Konieczny SF, Drobes BL, Menke SL, Taparowsky EJ 1989 Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene. Oncogene 4:473-481
21. Mitin N, Kudla AJ, Konieczny SF, Taparowsky EJ 2001 Differential effects of Ras signaling through NFκB on skeletal myogenesis. Oncogene 20:1276-1286
22. Weyman CM, Ramocki MB, Taparowsky EJ, Wolfman A 1997 Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras. Oncogene 14:697-704
23. Conejo R, de Alvaro C, Benito M, Cuadrado A, Lorenzo M 2002 Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-κB through an AKT/P70S6K/p38-MAPK pathway. Oncogene 21:3739-3753
24. Garcia JM, Gonzalez R, Silva JM, Dominguez G, Vegazo IS, Gamallo C, Provencio M, Espana P, Bonilla F 2000 Mutational status of K-ras and TP53 genes in primary sarcomas of the heart. Br J Cancer 82:1183-1185
25. Stratton MR, Fisher C, Gusterson BA, Cooper CS 1989 Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res 49:6324-6327
26. Oliva JL, Zarich N, Martinez N, Jorge R, Castrillo A, Azanedo M, Garcia-Vargas S, Gutierrez-Eisman S, Juarranz A, Bosca L, Gutkind JS, Rojas JM 2004 The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras. J Biol Chem 279:33480-33491
27. Blau HM, Pavlath GK, Hardeman EC, Chiu CP, Silberstein L, Webster SG, Miller SC, Webster C 1985 Plasticity of the differentiated state. Science 230:758-766
28. de Alvaro C, Teruel T, Hernandez R, Lorenzo M 2004 Tumor necrosis factor α produces insulin resistance in skeletal muscle by activation of inhibitor κB kinase in a p38 MAPK-dependent manner. J Biol Chem 279:17070-17078
29. Vlahos CJ, Matter WF, Hui KY, Brown RF 1994 A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4- one (LY294002). J Biol Chem 269:5241-5248
30. Kummer JL, Rao PK, Heidenreich KA 1997 Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem 272:20490-20494
31. Gallego MS, Sanchez de Toledo CJ 2007 Molecular biology of rhabdomyosarcoma. Clin Transl Oncol 9:415-419
32. Fedorov YV, Rosenthal RS, Olwin BB 2001 Oncogenic Ras-induced proliferation requires autocrine fibroblast growth factor 2 signaling in skeletal muscle cells. J Cell Biol 152:1301-1305
33. Suzuki J, Kaziro Y, Koide H 2000 Positive regulation of skeletal myogenesis by R-Ras. Oncogene 19:1138-1146
34. Galetic I, Maira SM, Andjelkovic M, Hemmings BA 2003 Negative regulation of ERK and Elk by protein kinase B modulates c-Fos transcription. J Biol Chem 278:4416-4423
35. Figueroa C, Vojtek AB 2003 Akt negatively regulates translation of the ternary complex factor Elk-1. Oncogene 22:5554-5561
36. Galbiati F, Volonte D, Engelman JA, Scherer PE, Lisanti MP 1999 Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J Biol Chem 274:30315-30321
37. Perdiguero E, Ruiz-Bonilla V, Gresh L, Hui L, Ballestar E, Sousa-Victor P, Baeza-Raja B, Jardi M, Bosch-Comas A, Esteller M, Caelles C, Serrano AL, Wagner EF, Munoz-Canoves P 2007 Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38 in abrogating myoblast proliferation. EMBO J 26:1245-1256
38. Cabane C, Englaro W, Yeow K, Ragno M, Derijard B 2003 Regulation of C2C12 myogenic terminal differentiation by MKK3/p38α pathway. Am J Physiol Cell Physiol 284:C658-C666
39. Tortorella LL, Lin CB, Pilch PF 2003 ERK6 is expressed in a developmentally regulated manner in rodent skeletal muscle. Biochem Biophys Res Commun 306:163-168
40. Tiffin N, Adi S, Stokoe D, Wu NY, Rosenthal SM 2004 Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation. Endocrinology 145:4991-4996
41. Cabane C, Coldefy AS, Yeow K, Derijard B 2004 The p38 pathway regulates Akt both at the protein and transcriptional activation levels during myogenesis. Cell Signal 16:1405-1415
42. Gonzalez I, Tripathi G, Carter EJ, Cobb LJ, Salih DA, Lovett FA, Holding C, Pell JM 2004 Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol Cell Biol 24:3607-3622
43. Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, Mochida K, Hata T, Matsuda J, Aburatani H, Nishino I, Ezaki O 2004 Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 279:41114-41123
44. Sumitani S, Goya K, Testa JR, Kouhara H, Kasayama S 2002 Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts. Endocrinology 143:820-828
45. Lee KH, Kim DG, Shin NY, Song WK, Kwon H, Chung CH, Kang MS 1997 NF-κB-dependent expression of nitric oxide synthase is required for membrane fusion of chick embryonic myoblasts. Biochem J 324:237-242